Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
3/13/17
1
ARW
GBSC 724: Advanced Topics in Metabolomics
Metabolomics in Models of Cardiovascular Disease
Wednesday, March 15, 2017
Adam R. Wende, Ph.D.
Assistant ProfessorDivision of Molecular and Cellular Pathology
ARW
Outline
• Define the question and model to determine the connection between metabolism and diabetic heart disease.
• Identify the molecular mechanisms by which glucose directly alters molecular function using systems biology.• Transcriptomics• Proteomics• Metabolomics• Epigenetics (e.g. methylomics)
3/13/17
2
ARW
2.5 million years 50 years
Obesity, Metabolic Syndrome, Diabetes,and Heart Failure
From: Roger Unger - UTSW
ARW www.cdc.gov/diabetes/statistics and www.cdc.gov/mmwr
2010 – Obesity
2010 – Diabetes 2010 – Heart Disease
2010 – Physical Inactivity
≤19% 20%–23% 24%–27% 28%-30% ≥31% 20%-24% 25%–29% ≥30%
3/13/17
3
ARW
Maintaining Cardiac Function Through Metabolic Substrate Balance
Glucose Fatty Acids
giphy.com
ARW Ungar … Bing 1955 Am J Med 18(3):385
UAB founded in 1969
3/13/17
4
ARW
Metabolic Substrate Utilization in the Heart
Peterson and Gropler 2010 Circ Cardiovasc Imaging 3:211
ARW
Point/Counterpoint - The Right Balance?
Taegtmeyer and Stanley 2011 J Mol Cell Cardiol 50(1):2
Heinrich Taegtmeyer, MD, DPhil
William C. Stanley, PhD
1957 - 2013
3/13/17
5
ARW
Diabetes and Metabolomics
Metabolomics is an integral part for understanding diseaseprocesses … information garnered in the biomarkerinvestigations, future research should shed more light ondisease pathogenesis and explore new treatment options.
ARW
Heart failure and substrate switching
The hypertrophy, oxidative stress, and metabolic changesthat occur within the heart when glucose supplants FA as amajor energy source suggest that substrate switching toglucose is not entirely benign.
3/13/17
6
ARW
Mitochondria – a Dynamic Network
Fan … Brooks 2010 Free Radic Biol Med 49(11):1646
ARW
Mitochondria – too much fat
Serum Serum + 500 μM Palmitate
Adapted from Heiko Bugger
3/13/17
7
ARWAsk for image credits
Fatty Acids
CACAcyl-Carnitine
FAO
Acetyl-CoA
ADP
ATPe-e-
e-
I II III IV
Metabolic Substrate Utilization
H+H+ H+
Glycogensynthase
Hexosamine biosynthetic pathway
UDP-GlcNAc
Acyl-CoA
e-
PDPs
PDKs
GlucoseO
P
GlucoseO
P
Glycolysis
Pyruvate
GLUT1
PDHAcetyl-
CoA
GLUT4
MPC1/2
PFK
HK
GlucoseO
O
TF TF
GLUT4
ARW
Facilitative Glucose Transporters: GLUTs“Solute Carrier Family, SLC2A”
Scheepers … Schurmann 2004 J Parenter Enteral Nutr 28:364
3/13/17
8
ARW
Changes in Human Heart GLUT Levels
Armoni … Karnieli 2005 J Biol Chem 280(41):34786
Biopsies obtained during coronary bypass surgeryHL = hyperlipidemiaDM2 = diabetes mellitus type 2
Razeghi … Taegtmeyer 2002 Cardiology 280(41):34786
RNAHuman heart failure
ProteinHuman heart diabetes
ARW
Glucose Utilization and Rodent Models of Type 1 Diabetes
Panagia … Clarke 2005 Am J Physiol 288:H2677
ProteinDiabetic Mouse Heart
GLUT4
Glucose UptakeDiabetic Mouse Heart
3/13/17
9
Glycolysis GLOX
Belke … Severson 2000 Am J Physiol 279:E1104
Constitutive GLUT4 Expression Prevents Development of Glucose Utilization Defects
Question: Is the change in cardiac metabolic substrate flexibility
adaptive or maladaptive?
3/13/17
10
DOX absent = OFF
MHC-rtTArtTAa-MHC
TRE-GLUT4mycGLUT4TRE
DOX present = ON
MHC-rtTArtTAa-MHC
TRE-GLUT4mycGLUT4TRE
Inducible Cardiomyocyte-Specific GLUT4 Expression (mG4H)
2 4 8
myc
Glut4
DOX (d)
Con
2 4 8
mG4H
0 14 0 14
Con mG4H
14
Hrt
GC
Va
s TA
S
ol
5-fold
2 4 8
myc
Glut4
DOX (d)
Con
2 4 8
mG4H
0 14 0 14
Con mG4H
14
Hrt
GC
Va
s TA
S
ol
5-fold
2 4 8
myc
Glut4
DOX (d)
Con
2 4 8
mG4H
0 14 0 14
Con mG4H
14
Hrt
GC
Va
s TA
S
ol
Heart
Hrt = HeartGC = GastrocnemiusVas = Vastus lateralis
TA = Tibialis anteriorSol = Soleus
mG4H Mice Exhibit Inducible Cardiac-Specific Expression of GLUT4
GLUT4
3/13/17
11
Ariel Contreras-FerratWende … Abel in prep
Insulin-induced GLUT4 Vesicle Fusion and Exofacial Myc-Epitope Exposure
Renata O. PereiraWende … Abel in prep
Cardiac Myocytes
2-DG Uptake
GLUT4 Induction Increases Basal and Insulin-Stimulated Glucose Uptake
Basal0.1 nM Ins
n = 3 – 4a P < 0.01 vs. Con-Basalb P < 0.001 vs. All
0
50
100
150
200
250
Con mG4H
pmol
! m
g-1 !
min
-1
b a
a a
3/13/17
12
TransgeneInduction
Streptozotocin (STZ)-Induced Hyperglycemia is Not Altered by Transgene Induction
ARW
0
300
600
900
1200
1500
1800
2100
Con mG4H
nmol
! m
in-1
! g
dhw
-1
GLUT4 Induction Increases Glycolysis andRescues Diabetic Cardiac Glycolytic Defects
n = 6 – 10§ P < 0.01 vs. Con
VehicleSTZ
Isolated Working Hearts
Glycolysis
0
300
600
900
1200
1500
1800
2100
Con mG4H
nmol
! m
in-1
! g
dhw
-1
§§
Joseph TuineiWende … Abel in prep
3/13/17
13
ARW
0
50
100
150
200
250
300
350
Con mG4H
nmol
! m
in-1
! g
dhw
-1
GLUT4 Induction Increases GLOX butAccelerates Diabetic Cardiac GLOX Defects
n = 6 – 10‡ P < 0.001 vs. All* P < 0.01 vs. Veh
VehicleSTZ
Isolated Working Hearts
Glucose Oxidation (GLOX)
0
50
100
150
200
250
300
350
Con mG4H
nmol
! m
in-1
! g
dhw
-1
*
‡
Joseph TuineiWende … Abel in prep
ARW
GLUT4 Induction Prevents Increased Cardiac POX in Diabetes
VehicleSTZ
Isolated Working Hearts
Palmitate Oxidation
(POX)
n = 5 – 13‡ P < 0.001 vs. All
0
100
200
300
400
500
600
Con mG4H
µm
ol !
min
-1 !
gdh
w-1
0
100
200
300
400
500
600
Con mG4H
µm
ol !
min
-1 !
gdh
w-1
‡
Joseph TuineiWende … Abel in prep
3/13/17
14
ARW
Oxidative Phosphorylation
www.genome.jp/kegg/pathway.html
ARW
GLUT4 Induction Accelerates Development of Mitochondrial Dysfunction
n = 3 – 4* P < 0.05
0
20
40
60
80
100
120
Con mG4H
Com
plex
I ac
tivity
(%
of C
on-V
eh)
0
20
40
60
80
100
120
Con mG4H
Com
plex
III a
ctiv
ity
(% o
f Con
-Veh
)
0
20
40
60
80
100
Con mG4H
Com
plex
II a
ctiv
ity
(% o
f Con
-Veh
)
0
20
40
60
80
100
Con mG4H
Com
plex
IV a
ctiv
ity
(% o
f Con
-Veh
)
* ** *
* *
Oleh KhalimonchukWende … Abel in prep
3/13/17
15
ARW
In the context of diabetes, enhancing glucose delivery by
expression of GLUT4 accelerates the progression of
mitochondrial dysfunction.
Conclusion – Part 1
ARW
Diabetic Cardiomyopathy“Death by a Thousand Cuts…”
ER stress
Adapted from Wende, Symons, and Abel 2012 Curr Hypertens Rep 14(6):517
Inflammation
Mitochondrial dysfunction
REDOX Imbalance
Lipotoxicity
Glucotoxicity
Insulin resistance
3/13/17
16
ARW Adapted from Lewis and Abdel-Haleem 2013 Front Physiol 4:237
Systems BiologyTranscriptome Genome
/EpigenomePhenome
Proteome Metabolome
PhenomeObesity, diabetes, heart failure, BHI, etc.
TranscriptomeNortherns, qPCR, microarrayRNA-seq, miR, lncRNA, etc.
ProteomeMass spec, western blot, Co-IP, IHC, PTMs, etc.
MetabolomeGlucometer, ELISA, GC-MS, HPLC, NMR, fluxomics, etc.
Genome / EpigenomeSoutherns, sequencing,GenBank, ENCODE, ChIP-seq, bsDNA-seq, etc.
ARW
Transcriptomic Analysis Using theAgilent SurePrint G3 60K Microarray
181.9 MB
mG4H-Veh
3/13/17
17
ARW
Pathway Analysis of Microarray
Wende … Abel in prep
-log(p-value)
Metabolic disease
Amino acid metabolism
Lipid metabolism
Nucleic acid metabolism
Carbohydrate metabolism
Skeletal and muscular disorders
Energy production
Cardiovascular system development & function
Post-translational modification
Endocrine system development & function
Inflammatory response
Endocrine system disorders
Cell death
Cardiovascular disease
Gene expression
Nutritional disease
Protein degradation
Threshold0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
ARW
Glucose Regulated Gene Expression
Wende, unpublished
0 = up-regulated0 = contra-regulated0 = down-regulated
MouseSTZ
MousemG4H
3/13/17
18
ARW
Species Conservation of Gene Expression Changes in Diabetes
Drakos … Wende, unpublished
HumanT1D
MouseT1D
ARW
Species Conservation of Gene Expression Changes in Diabetes
Drakos … Wende, unpublished
0.5 1.0 1.5 2.0 0.0 2.5
-log (P-value)
3.0 3.5 4.0
Threshold
Mitochondrial dysfunction
Calcium signaling
3-phosphoinositide degradation
Oxidative phosphorylation
3/13/17
19
ARW
Oxidative Phosphorylation
GeneSifter using KEGG
ARW
Ndufa9 Gene Promoter Structure
KEYTSS = Transcription start site
= CpG island
= Sp1 RE
http://ecrbrowser.dcode.org
3/13/17
20
ARW
-2 kb +1 kb
Luc
-0.5 kb
-0.3 kb
TSS
Ndufa9
Ndufa9 Gene Promoter Mapping
C2C12 Myotubesn = 9* P < 0.05
5.5 mM 25 mM
Glucose
0
20
40
60
80
100
-2 kb -0.5 kb -0.3 kb
Nor
mal
ized
RLU
*
* *
Wende … Abel in prep
Transient Transfection
Promoter Activity
ARW
0
20
40
60
80
100
-2 kb WT -2 kb M3
Nor
mal
ized
RLU
Ndufa9 Gene Promoter Mapping
C2C12 Myotubesn = 9* P < 0.05
5.5 mM 25 mM
Glucose
*
-2 kb +1 kb
Luc
TSS
Ndufa9 Sp1-M3
Wende … Abel in prep
Transient Transfection
Promoter Activity
3/13/17
21
ARW
0
20
40
60
80
100
-2 kb + (-) -2 kb + Sp1
Nor
mal
ized
RLU
Ndufa9 Gene Promoter Mapping
C2C12 Myotubesn = 9* P < 0.05
5.5 mM 25 mM
Glucose
*
*
*
*
-2 kb +1 kb
Luc
TSS
Ndufa9
Sp1
Wende … Abel in prep
Transient Transfection
Promoter Activity
ARW Adapted from Lewis and Abdel-Haleem 2013 Front Physiol 4:237
Systems BiologyTranscriptome Genome
/EpigenomePhenome
Proteome Metabolome
PhenomeObesity, diabetes, heart failure, BHI, etc.
TranscriptomeNortherns, qPCR, microarrayRNA-seq, miR, lncRNA, etc.
ProteomeMass spec, western blot, Co-IP, IHC, PTMs, etc.
MetabolomeGlucometer, ELISA, GC-MS, HPLC, NMR, fluxomics, etc.
Genome / EpigenomeSoutherns, sequencing,GenBank, ENCODE, ChIP-seq, bsDNA-seq, etc.
3/13/17
22
ARW
O-GlcNAcylation
ARW
Metabolic Integration: Protein O-GlcNAcylation
Hart … Lagerlof 2011 Annu Rev Biochem 80:825
-log(p-value)
Amino acid metabolism
Lipid metabolism
Nucleic acid metabolism
Carbohydrate metabolism
Threshold0 1 2 3 4 5 6 7 8 9 10
Microarray data
3/13/17
23
ARW
O-GlcNAc Cycling
Hanover … Love 2012 Nat Rev Mol Cell Biol 13(5):312
ARW
GlcNAc Regulation of Sp1
Vosseller … Hart 2002 Curr Opin Chem Biol 6(6):851
3/13/17
24
ARW
GlcNAcylation Regulates Ndufa9 Gene Expression
0
20
40
60
80
100
120
None GFP OGA
Nor
mal
ized
RLU
C2C12 Myotubesn = 3* P < 0.05
5.5 mM 25 mM
Glucose
Li WangWende … Abel in prep
Transient Transfection
Promoter Activity
0
20
40
60
80
100
120
None GFP OGA
Nor
mal
ized
RLU
*
ARW
Enhanced glucose delivery regulates oxidative capacity
via transcriptional mechanisms including GlcNAcylation of
transcription factors.
Conclusion – Part 2
3/13/17
25
ARW
Mitochondrial Protein O-GlcNAcylation and Neonatal Cardiomyocyte Metabolic Function
Hu … Dillmann 2009 J Biol Chem 284(1):547
Mitochondrial Protein O-GlcNAcylation
O-GlcNAcylation of NDUFA9
5.5 mM Glc 30 mM Glc+ Adv (-)
30 mM Glc+ Adv-OGA
Complex I Activity
5.5 mMGlc
30 mM Glc 30 mM Glc+ Adv (-)
30 mM Glc+ Adv-GCA
ARW
2D-PAGE
15%
SD
S-P
AG
E Con-STZ mG4H-Veh
pH 10 pH 3 IEF pH 10 pH 3 IEF
GLUT4 Induction Alters the Cardiac Mitochondrial Glycoproteome
Isolated Mitochondria
2D-PAGEPro-Q
Emerald
Hansjörg Schwertz Wende, unpublished
2D-PAGE
15%
SD
S-P
AG
E Con-STZ mG4H-Veh
pH 10 pH 3 IEF pH 10 pH 3 IEF
Con-Veh Con-STZ
3/13/17
26
ARW Adapted from Lewis and Abdel-Haleem 2013 Front Physiol 4:237
Systems BiologyTranscriptome Genome
/EpigenomePhenome
Proteome Metabolome
PhenomeObesity, diabetes, heart failure, BHI, etc.
TranscriptomeNortherns, qPCR, microarrayRNA-seq, miR, lncRNA, etc.
ProteomeMass spec, western blot, Co-IP, IHC, PTMs, etc.
MetabolomeGlucometer, ELISA, GC-MS, HPLC, NMR, fluxomics, etc.
Genome / EpigenomeSoutherns, sequencing,GenBank, ENCODE, ChIP-seq, bsDNA-seq, etc.
ARW
Metabolomic Signatures of Diabetic Heart Disease
James CoxGC and HPLC - metabolomics
KEYCon-VehCon-STZmG4H-VehmG4H-STZ
3D – PCA
3/13/17
27
ARW Ungar … Bing 1955 Am J Med 18(3):385
ARW
BHB
GLUT4 Induction Alters Cardiac Ketone Utilization Genes
Manoja Brahma
KetoneSynthesis
Acetoacetate
AcAc-CoA
m-Thiolase/Acaa2
Acetyl-CoA
KetoneOxidation
RNA - Microarray-1 1
AcAc-CoA
Acetyl-CoA
HMG-CoA
Acetoacetate
BHB
HMGCS2/Hmgcs2
Fatty acids
CAC
BDH1/Bdh1
SCOT/Oxct1
3/13/17
28
ARW Manoja Brahma
GLUT4 Induction Alters Cardiac Ketone Protein GlcNAcylation
GlcNAc
SCOT1
Overlay
Input IP– SCOT1
ARW
Enhanced cardiac glucose delivery alters metabolic flux through other pathways and regulates the mitochondrial
proteome via O-GlcNAcylation.
Conclusion – Part 3
3/13/17
29
ARW Adapted from Lewis and Abdel-Haleem 2013 Front Physiol 4:237
Systems BiologyTranscriptome Genome
/EpigenomePhenome
Proteome Metabolome
PhenomeObesity, diabetes, heart failure, BHI, etc.
TranscriptomeNortherns, qPCR, microarrayRNA-seq, miR, lncRNA, etc.
ProteomeMass spec, western blot, Co-IP, IHC, PTMs, etc.
MetabolomeGlucometer, ELISA, GC-MS, HPLC, NMR, fluxomics, etc.
Genome / EpigenomeSoutherns, sequencing,GenBank, ENCODE, ChIP-seq, bsDNA-seq, etc.
ARW Broad Institute Communications
From Human to Mouse and Back Again
3/13/17
30
ARW
Role of Epigenetics in Gene Expression
ARW
Epigenetics - Programming DCCT: Diabetes Control and Complications Trial
3/13/17
31
ARW
Epigenetics - MemoryEDIC: Epidemiology of Diabetes Interventions Trial
Pirola … El-Osta 2010 Nat Rev Endocrinol 6(12):665
ARW
Epigenetics: Transgenerational and Drift
Gut and Verdin 2013 Nature 502:489
3/13/17
32
ARW Fischer 2014 EMBO J 33(9):945:489
Epigenetic Code
ARW Gräff and Tsai 2013 Nat Rev Neurosci 14(2):97
Chromatin Regulation
3/13/17
33
ARW
How do metabolites fit in?
Arnaudo … Garcia 2013 Epigenetics Chromatin 6(1):24
ARW
Metabolite Signaling to Chromatin
Gut and Verdin 2013 Nature 502:489
3/13/17
34
ARW
How does GlcNAc fit in?
Gut and Verdin 2013 Nature 502(7472):489
ARW ucsf.edu
DNA Methylation 101
3/13/17
35
ARW
Exercise Alters DNA Methylation of Key Metabolic Genes
Low = 40% VO2peak High = 80% VO2peak
Subjects fasted overnight and then consumed a high carbohydrate diet 4 hr prior to exercise.
Barres and Zierath 2012 Cell Metab 15:405
ARW
Diabetes Regulated Cardiac DNA Methylation
Pdk4
= C, = 5mC CpG :
Ndufa9
Con STZ
-552 bp -301 bp
Con STZ *
| |
-523 bp -259 bp | |
Wende, unpublished
Pdk4
= C, = 5mC CpG :
Ndufa9
Con STZ
-552 bp -301 bp
Con STZ *
| |
-523 bp -259 bp | |
Pdk4
= C, = 5mC CpG :
Ndufa9
Con STZ
-552 bp -301 bp
Con STZ *
| |
-523 bp -259 bp | |
Heart, LVn = 10* P < 0.05
TargetedbsDNA-seq
5-mCpG
3/13/17
36
ARW
Methylation and Expression
GeneSifter and Zymo/UCSC Genome Browser
RNA – microarray
Methylation – genome sequencing Legend:
0% 100%
PDK4
VDAC
Protein – western blotCon mG4H
Veh STZ Veh STZ
ARW
Other Human/Mouse Comparisons
Irvin … Arnett 2014 Circulation 130:565
3/13/17
37
ARW
Other Human/Mouse ComparisonsMouse
Gene ExpressionConVeh
ConSTZ
mG4HVeh
mG4HSTZ GENE
Mouse DNA Methylation
Wende, unpublished
ARW
Where Does Glycemic Memory Fit In?
DOX absent = OFF
MHC-rtTArtTAa-MHC
TRE-GLUT4mycGLUT4TRE
DOX present = ON
MHC-rtTArtTAa-MHC
TRE-GLUT4mycGLUT4TRE
3/13/17
38
ARW
Metabolomics
Wende, unpublished
Con-STZ mG4H-Veh
mG4H-STZ Con-Veh mG4H-1wk mG4H-2wk
ON OFF
ARW
Glucose Cycling AltersEpigenetic Programming
Legend:
0% 100%
Heart, LV Zymo ResearchWende, unpublished
GenomewidebsDNA-seq
5-mCpG
mG4H-ON
mG4H-OFF
3/13/17
39
ARW
Background
http://chemistry.uchicago.edu/faculty/faculty/person/member/chuan-he.html
5-hmC Wyatt and Cohen 1952 Nature 170(4338):1072Kriaucioni and Heintz 2009 Science 324(5929):929Tahiliani … Rao 2009 Science 324(5929):930
ARW
How does GlcNAc fit in?
Mariappa … Aalten 2013 EMBO J 32:612
3/13/17
40
ARW
Cellular glucose fluctuations regulates the epigenome via
histone modifications and controlling the machinery for
DNA methylation.
Conclusion – Part 4
ARW
Sugar Gumming Up the Works
giphy.com
GLUT4Glucose
OO
GlucoseO
O GLUT4Glucose
OO
GlucoseO
O
GlucoseO
O
GlucoseO
O
GlucoseO
O
3/13/17
41
ARW
Using combined methylomics, transcriptomics, proteomics, and metabolomics we have
begun to define the mechanism of glucotoxicity.
Overall Summary
ARW
Acknowledgements
Knowledge)that)will)change)your)world)
UAB)
UAB)
Division)of)Molecular)and)Cellular)Pathology)
Thomas J Bailey – UndergradManoja K. Brahma – PostdocMark C. McCrory – Lab ManagerBrenna G. Nye – UndergradMark Pepin – MSTPLamario J Williams – Undergrad
Wende Lab
K99R00 HL111322R00 HL111322-S1
U24 DK076169 AHA 0725064Y JDRF 51002608
Other Colleagues & Mentorspast and present
Oleh Khalimonchuk – UNL
Hansjörg Schwertz
E. Dale AbelJohn C. Schell Joseph Tuineimany others…
UAB CollaboratorsSteve Barnes
John C. ChathamDavid K. CrossmanSteve M. PogwizdMartin E. Young
Stavros G. DrakosNikos A. Diakos